Skip to content
Procainamide

Structure via PubChem · Public domain (PubChem)

EntityQ417597· pop 26· linked from 399 articles

Procainamide

Sign in to save

Also known as Procan®, Pronestyl®, p-Aminobenzoic diethylaminoethylamide, p-Amino-N-(2-diethylaminoethyl)benzamide, Biocoryl, Procainamida, Procainamidum

Procainamide (PCA) is a medication of the antiarrhythmic class used for the treatment of cardiac arrhythmias. It is a sodium channel blocker of cardiomyocytes; thus it is classified by the Vaughan Williams classification system as class Ia. In addition to blocking the INa current, it inhibits the IKr rectifier K+ current. Procainamide is also known to induce a voltage-dependent open channel block on the batrachotoxin (BTX)-activated sodium channels in cardiomyocytes.

Chemical data

Formula
C13H21N3O
Molecular weight
235.33 g/mol
IUPAC name
4-amino-N-[2-(diethylamino)ethyl]benzamide
SMILES
CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
InChIKey
REQCZEXYDRLIBE-UHFFFAOYSA-N
XLogP
0.9
Polar surface area
58.4 Ų
H-bond donors
2
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1950
Admin. routes
oral, parenteral
Indications
atrial fibrillation, heart failure, cardiac arrhythmia, myocardial infarction

via ChEMBL · EBI

Wikidata facts

Mass
235.168462
Has use
medication
Show 7 more facts
significant drug interaction
thioridazine
chemical formula
C₁₃H₂₁N₃O
medical condition treated
supraventricular tachycardia
canonical SMILES
CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
World Health Organisation international non-proprietary name
procainamide
Commons category
Procainamide
has characteristic
bitterness
Sources (3)

via Wikidata · CC0